These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6188886)

  • 1. Effects of the calcium antagonist PY 108-068 on myocardial tissues in vitro and on reflex tachycardia in vivo.
    Hof RP; Scholtysik G
    J Cardiovasc Pharmacol; 1983; 5(2):176-83. PubMed ID: 6188886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro negative chronotropic and inotropic effects of a novel dihydropyridine derivative, CD-832, in the guinea-pig: comparison with calcium-channel antagonists.
    Noguchi K; Takahashi K; Higuchi S
    J Pharm Pharmacol; 1998 Mar; 50(3):329-34. PubMed ID: 9600727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PY 108-068: a calcium antagonist with an unusual pattern of cardiovascular activity.
    Hof RP
    Gen Pharmacol; 1985; 16(1):1-6. PubMed ID: 2579873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PN 200-110, a new calcium antagonist: electrophysiological, inotropic, and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta.
    Hof RP; Scholtysik G; Loutzenhiser R; Vuorela HJ; Neumann P
    J Cardiovasc Pharmacol; 1984; 6(3):399-406. PubMed ID: 6202964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inotropic and electrophysiological effects of PY 108-068 on isolated cardiac preparations.
    Tejerina MT; Delgado C; Diez J; Tamargo J
    Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):64-80. PubMed ID: 6497511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative selectivity for negative chronotropic and inotropic effects of a novel dihydropyridine derivative CD-832.
    Noguchi K; Masumiya H; Sasaki T; Takahashi K; Araki H; Higuchi S; Tanaka H; Shigenobu K
    Eur J Pharmacol; 1996 Jul; 308(1):53-9. PubMed ID: 8836632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reflex chronotropic and inotropic effects of calcium channel-blocking agents in conscious dogs. Diltiazem, verapamil, and nifedipine compared.
    Nakaya H; Schwartz A; Millard RW
    Circ Res; 1983 Mar; 52(3):302-11. PubMed ID: 6825222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro assessment for vascular selectivity of a new dihydropyridine derivative, NB-818.
    Hattori Y; Fukao M; Houzen H; Qi F; Yamada Y; Kanno M
    Eur J Pharmacol; 1996 Apr; 301(1-3):99-106. PubMed ID: 8773452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative inotropic properties of isradipine, nifedipine, diltiazem, and verapamil in diseased human myocardial tissue.
    Schwinger RH; Böhm M; Erdmann E
    J Cardiovasc Pharmacol; 1990 Jun; 15(6):892-9. PubMed ID: 1694911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac versus vascular effects of a new dihydropyridine derivative, CV-4093. In vitro comparison with other calcium antagonists.
    Nakaya H; Hattori Y; Nakao Y; Kanno M
    Eur J Pharmacol; 1988 Jan; 146(1):35-43. PubMed ID: 3350058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional antagonism between calcium-antagonists and noradrenaline on isolated guinea-pig atria.
    Görlitz BD; Wagner J; Schümann HJ
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 288(2-3):311-7. PubMed ID: 1161050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms.
    Millard RW; Lathrop DA; Grupp G; Ashraf M; Grupp IL; Schwartz A
    Am J Cardiol; 1982 Feb; 49(3):499-506. PubMed ID: 6277175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of two new calcium antagonists, PY 108-068 and PN 200-110, in conscious spontaneously hypertensive rats.
    Barrès C; Cerutti C; Morin B; Sassard J
    Br J Pharmacol; 1988 Jan; 93(1):176-84. PubMed ID: 2964887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial and vascular effects of efonidipine in vitro as compared with nifedipine, verapamil and diltiazem.
    Tanaka H; Masumiya H; Sekine T; Sijuku T; Sugahara M; Taniguchi H; Terada M; Saito W; Shigenobu K
    Gen Pharmacol; 1996 Apr; 27(3):451-4. PubMed ID: 8723524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hypoxia, elevated K+ and acidosis on the potency of verapamil, diltiazem and nifedipine in the guinea-pig isolated papillary muscle.
    Robertson MJ; Lumley P
    Br J Pharmacol; 1989 Nov; 98(3):937-49. PubMed ID: 2590774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of 2-[(diethylamino)acetyl]-1,2,3,4-tetrahydro-6, 7-dimethoxyl-1-[1'-(6"-methoxy-2"-naphthalenyl)ethyl]-isoquinoline on isolated guinea pig papillary muscle and heart atrium.
    Wu GT; Dong H; Liang ZJ
    Zhongguo Yao Li Xue Bao; 1995 May; 16(3):239-42. PubMed ID: 7660819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular profile of MPC-1304, a novel dihydropyridine calcium antagonist: comparison with other calcium antagonists.
    Kanda A; Haruno A; Miyoshi K; Tanahashi Y; Miyake H; Ichihara K; Okumura K; Nagasaka M
    J Cardiovasc Pharmacol; 1993 Jul; 22(1):167-75. PubMed ID: 7690090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary vasodilator compared to cardiac effects of PY 108-068, a new dihydropyridine vasodilator, on isolated, blood-perfused dog-heart preparations.
    Wada Y; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1984; 6(5):881-7. PubMed ID: 6209495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the cardiac and vasodilatory effects of some calcium entry blockers in perfused isolated guinea-pig hearts.
    Boddeke HW; Wilffert B; Heynis JB; van de Haar Keuken V; Jonkman FA; van Zwieten PA
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):175-85. PubMed ID: 3675080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.